In 2009, Governor O’Malley proposed a record $1.3
billion, 10-year investment, to propel the life science sector
even further, faster. As of July 2011, we have invested
well over $300 million in areas such as strategic research
like stem cells, provided grants and tax incentives
to commercialize and develop biotech companies, and
committed dollars to key infrastructure such as bioparks
and incubation space next to our flagship universities.
Our end objective is to position Maryland to be a leading
global region for the discovery and commercialization of
life sciences products and services (see Chart 4).